This inventor holds 1 USPTO granted patent. Top assignee: Pharma Mar, S.a.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Jean Louis Misset: Innovator in Cancer Treatment
Introduction
Jean Louis Misset is a notable inventor based in Villejuif, France. He has made significant contributions to the field of medicine, particularly in cancer treatment. His innovative work has led to the development of a patent that addresses critical health challenges.
Latest Patents
Jean Louis Misset holds a patent for "Compositions and uses of ET743 for treating cancer." This patent focuses on ET743, which is utilized in the preparation of a medicament for the treatment of the human body for cancer. His work in this area highlights the potential of ET743 as a therapeutic agent.
Career Highlights
Misset is associated with Pharma Mar, S.A., a company dedicated to the research and development of innovative medicines. His role in this organization has allowed him to contribute to groundbreaking advancements in cancer treatment.
Collaborations
Throughout his career, Jean Louis Misset has collaborated with esteemed colleagues such as George Daniel Demetri and Jose Jimeno. These partnerships have fostered a collaborative environment that enhances research and development efforts in oncology.
Conclusion
Jean Louis Misset's contributions to cancer treatment through his patent and collaborations underscore his importance in the field of medical innovation. His work continues to inspire advancements that may lead to improved therapies for patients battling cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile